| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/27/2026 | ±7.7% | +2.4% | over-priced |
| 05/08/2026 | ±10.1% | +7.7% | over-priced |
| 02/05/2026 | ±15.7% | -11.5% | over-priced |
| 11/06/2025 | ±11.3% | -12.4% | under-priced |
| 05/08/2026 | ±10.1% | +7.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | — | $137M | $-684M |
| Q3 FY2026 | $-0.74 | $145M | $-248M |
| Q2 FY2026 | $-0.52 | $185M | $-155M |
| Q1 FY2026 | $1.08 | $240M | $385M |
IREN Limited Ordinary Shares (IREN) reports in 12 days, with the next report estimated for 11/09/2026. Across the last 5 reports, options priced an average ±11.0% earnings move while the stock actually moved 8.3% on average — the market has systematically over-priced IREN's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue down 5.2%. QuantLogix's live 5-factor engine currently reads IREN as a underweight at 23/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →